Why is Japan Tissue Engineering Co., Ltd. ?
- The company has been able to generate a Return on Equity (avg) of 0.47% signifying low profitability per unit of shareholders funds
- PRE-TAX PROFIT(Q) At JPY -241.21 MM has Fallen at -311.47%
- NET PROFIT(Q) At JPY -242.39 MM has Fallen at -279.77%
- RAW MATERIAL COST(Y) Grown by 9.3% (YoY)
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -0.41%, its profits have fallen by -278.3%
- Along with generating -0.41% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Japan Tissue Engineering Co., Ltd. for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Higher at JPY -147.64 MM
Highest at 7.28%
At JPY -241.21 MM has Fallen at -311.47%
At JPY -242.39 MM has Fallen at -279.77%
Grown by 9.3% (YoY
Lowest at JPY 7,806.91 MM
Lowest at JPY 426.37 MM
Lowest at JPY -204.91 MM
Lowest at -48.06 %
Lowest at JPY -5.97
Here's what is working for Japan Tissue Engineering Co., Ltd.
Debtors Turnover Ratio
Here's what is not working for Japan Tissue Engineering Co., Ltd.
Net Sales (JPY MM)
Pre-Tax Profit (JPY MM)
Net Profit (JPY MM)
Net Sales (JPY MM)
Operating Profit (JPY MM)
Operating Profit to Sales
Pre-Tax Profit (JPY MM)
Net Profit (JPY MM)
EPS (JPY)
Cash and Cash Equivalents
Raw Material Cost as a percentage of Sales






